SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001144204-13-001938
Filing Date
2013-01-11
Accepted
2013-01-11 16:01:32
Documents
1
Period of Report
2013-01-11

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A v331875_pre14a.htm PRE 14A 617017
  Complete submission text file 0001144204-13-001938.txt   618054
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: PRE 14A | Act: 34 | File No.: 000-25169 | Film No.: 13525520
SIC: 2834 Pharmaceutical Preparations